Skip to main content
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
7.67
-0.55 (-6.69%)
At close: Mar 28, 2025, 4:00 PM
7.73
+0.06 (0.79%)
After-hours: Mar 28, 2025, 4:16 PM EDT

Adaptive Biotechnologies Revenue

In the year 2024, Adaptive Biotechnologies had annual revenue of $178.96M with 5.10% growth. Adaptive Biotechnologies had revenue of $47.46M in the quarter ending December 31, 2024, with 3.66% growth.

Revenue (ttm)
$178.96M
Revenue Growth
+5.10%
P/S Ratio
6.76
Revenue / Employee
$289,107
Employees
619
Market Cap
1.14B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024178.96M8.68M5.10%
Dec 31, 2023170.28M-15.03M-8.11%
Dec 31, 2022185.31M30.96M20.06%
Dec 31, 2021154.34M55.96M56.88%
Dec 31, 202098.38M13.31M15.65%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ADPT News

More News